ArticlemAbs

Glycovariant anti-CD37 monospecific protein therapeutic exhibits enhanced effector cell-mediated cytotoxicity against chronic and acute B cell malignancies.

Sarwish Rafiq et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.